Visby Medical is working to change the order of diagnosis and treatment of infectious disease. The company developed a Flu-COVID PCR Test that will offer rapid PCR testing in a single-use, all-in-one device that fits in the palm of your hand. Designed for ease-of-use with no set-up time, and a fast sample-to-result time of less than 30 minutes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/01/2022 | Series E | $108.62MM | $xx.xx | $1.16B | Artiman Ventures, Blue Water Life Science Advisors, Cedars Sinai Medical Center, Healthcare Of Ontario Pension Plan, John Doerr, Nd Capital, Nissim Capital, Ping An Voyager Partners, Pitango Venture Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,368,785
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artiman Ventures, Blue Water Life Science Advisors, Cedars Sinai Medical Center, Healthcare Of Ontario Pension Plan, John Doerr, Nd Capital, Nissim Capital, Ping An Voyager Partners, Pitango Venture Capital
|
||||||
05/07/2020 | Series D | $165.87MM | $xx.xx | $905.83MM | J-Ventures, Valo Ventures | |
Price per Share
$xx.xx
Shares Outstanding
5,154,559
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
J-Ventures, Valo Ventures
|
||||||
04/05/2019 | Series C | $116.46MM | $xx.xx | $414.23MM | Artiman Ventures, Valo Ventures | |
Price per Share
$xx.xx
Shares Outstanding
5,748,128
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artiman Ventures, Valo Ventures
|
||||||
11/15/2015 | Series B | $16MM | $xx.xx | $51.62MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,571,428
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/01/2012 | Series A | $6.02MM | $xx.xx | $12.03MM | Artiman Ventures | |
Price per Share
$xx.xx
Shares Outstanding
5,014,577
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artiman Ventures
|